Literature DB >> 34939322

Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature.

Astrid Wintering1, Stephen Smith2, Beng Fuh3, Arun Rangaswami1, Gary Dahl4, May Chien4, Tanja A Gruber4, Jinjun Dang4, Loretta S Li5, Alicia Lenzen5, Stephanie Savelli6, Christopher C Dvorak1,7, Anurag K Agrawal2,7, Elliot Stieglitz1,7.   

Abstract

Therapy-related myeloid neoplasms (t-MN) are a distinct subgroup of myeloid malignancies with a poor prognosis that include cases of therapy-related myelodysplastic syndrome (t-MDS), therapy-related myeloproliferative neoplasms (t-MPN) and therapy-related acute myeloid leukemia (t-AML). Here, we report a series of patients with clinical features consistent with juvenile myelomonocytic leukemia (JMML), an overlap syndrome of MDS and myeloproliferative neoplasms that developed after treatment for another malignancy.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  AML; JMML; MDS; secondary; therapy related

Mesh:

Year:  2021        PMID: 34939322      PMCID: PMC8957526          DOI: 10.1002/pbc.29499

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  32 in total

Review 1.  How I treat juvenile myelomonocytic leukemia.

Authors:  Franco Locatelli; Charlotte M Niemeyer
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

2.  High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.

Authors:  V Grossmann; S Schnittger; F Poetzinger; A Kohlmann; A Stiel; C Eder; A Fasan; W Kern; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2013-03-28       Impact factor: 11.528

Review 3.  A focused review of hematopoietic neoplasms occurring in the therapy-related setting.

Authors:  Liping Zhang; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

Review 4.  Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.

Authors:  Franco Locatelli; Mattia Algeri; Pietro Merli; Luisa Strocchio
Journal:  Expert Rev Hematol       Date:  2018-01-03       Impact factor: 2.929

Review 5.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

6.  Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.

Authors:  Ryoichi Ono; Hideaki Nakajima; Katsutoshi Ozaki; Hidetoshi Kumagai; Toshiyuki Kawashima; Tomohiko Taki; Toshio Kitamura; Yasuhide Hayashi; Tetsuya Nosaka
Journal:  J Clin Invest       Date:  2005-03-10       Impact factor: 14.808

Review 7.  Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.

Authors:  Daniel K Choi; Irene Helenowski; Nobuko Hijiya
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

8.  Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

Authors:  N J Winick; R W McKenna; J J Shuster; N R Schneider; M J Borowitz; W P Bowman; D Jacaruso; B A Kamen; G R Buchanan
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

9.  Cytogenetics of juvenile type chronic granulocytic leukemia.

Authors:  S Inoue; Y Ravindranath; R I Thompson; W W Zuelzer; M J Ottenbreit
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

10.  The genomic landscape of juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Amaro N Taylor-Weiner; Tiffany Y Chang; Laura C Gelston; Yong-Dong Wang; Tali Mazor; Emilio Esquivel; Ariel Yu; Sara Seepo; Scott Olsen; Mara Rosenberg; Sophie L Archambeault; Ghada Abusin; Kyle Beckman; Patrick A Brown; Michael Briones; Benjamin Carcamo; Todd Cooper; Gary V Dahl; Peter D Emanuel; Mark N Fluchel; Rakesh K Goyal; Robert J Hayashi; Johann Hitzler; Christopher Hugge; Y Lucy Liu; Yoav H Messinger; Donald H Mahoney; Philip Monteleone; Eneida R Nemecek; Philip A Roehrs; Reuven J Schore; Kimo C Stine; Clifford M Takemoto; Jeffrey A Toretsky; Joseph F Costello; Adam B Olshen; Chip Stewart; Yongjin Li; Jing Ma; Robert B Gerbing; Todd A Alonzo; Gad Getz; Tanja Gruber; Todd Golub; Kimberly Stegmaier; Mignon L Loh
Journal:  Nat Genet       Date:  2015-10-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.